180 related articles for article (PubMed ID: 35274173)
21. Percutaneous thermoablation of small renal masses (T1a) in surgical candidate patients: oncologic outcomes.
Zangiacomo RN; Martins GLP; Viana PCC; Horvat N; Arap MA; Nahas WC; Srougi M; Cerri GG; Menezes MR
Eur Radiol; 2021 Jul; 31(7):5370-5378. PubMed ID: 33392662
[TBL] [Abstract][Full Text] [Related]
22. Oncological outcomes and complication rates after laparoscopic-assisted cryoablation: a European Registry for Renal Cryoablation (EuRECA) multi-institutional study.
Nielsen TK; Lagerveld BW; Keeley F; Lughezzani G; Sriprasad S; Barber NJ; Hansen LU; Buffi NM; Guazzoni G; van der Zee JA; Ismail M; Farrag K; Emara AM; Lund L; Østraat Ø; Borre M
BJU Int; 2017 Mar; 119(3):390-395. PubMed ID: 27488479
[TBL] [Abstract][Full Text] [Related]
23. Percutaneous cryoablation for recurrent low grade renal cell carcinoma after failed nephron-sparing surgery.
Morgan MA; Roberts NR; Pino LA; Trabulsi EJ; Brown DB; Gomella LG; Lallas CD
Can J Urol; 2013 Oct; 20(5):6933-7. PubMed ID: 24128832
[TBL] [Abstract][Full Text] [Related]
24. Long-term outcomes of CT-guided percutaneous cryoablation of T1a and T1b renal cell carcinoma.
Spiliopoulos S; Marzoug A; Ra H; Arcot Ragupathy SK
Diagn Interv Radiol; 2021 Jul; 27(4):524-528. PubMed ID: 34313238
[TBL] [Abstract][Full Text] [Related]
25. Percutaneous cryoablation of stage T1b renal cell carcinoma: technique considerations, safety, and local tumor control.
Atwell TD; Vlaminck JJ; Boorjian SA; Kurup AN; Callstrom MR; Weisbrod AJ; Lohse CM; Hartman WR; Stockland AH; Leibovich BC; Schmit GD; Thompson RH
J Vasc Interv Radiol; 2015 Jun; 26(6):792-9. PubMed ID: 25824313
[TBL] [Abstract][Full Text] [Related]
26. Percutaneous cryoablation versus partial nephrectomy for cT1b renal tumors: An inverse probability weight analysis.
Aikawa K; Yanagisawa T; Fukuokaya W; Shimizu K; Miyajima K; Nakazono M; Iwatani K; Matsukawa A; Obayashi K; Kimura S; Tsuzuki S; Sasaki H; Abe H; Sadaoka S; Miki J; Kimura T
Urol Oncol; 2023 Mar; 41(3):150.e11-150.e19. PubMed ID: 36604229
[TBL] [Abstract][Full Text] [Related]
27. Long-term oncologic outcomes after radiofrequency ablation for T1 renal cell carcinoma.
Psutka SP; Feldman AS; McDougal WS; McGovern FJ; Mueller P; Gervais DA
Eur Urol; 2013 Mar; 63(3):486-92. PubMed ID: 22959191
[TBL] [Abstract][Full Text] [Related]
28. Local ablation vs partial nephrectomy in T1N0M0 renal cell carcinoma: An inverse probability of treatment weighting analysis.
Shi L; He Y; Liu C; Qian X; Wang Z
Cancer Med; 2020 Nov; 9(21):7988-8003. PubMed ID: 32888392
[TBL] [Abstract][Full Text] [Related]
29. Renal fossa recurrence after radical nephrectomy: Current management, and oncological outcomes.
Romeo A; Garcia Marchiñena P; Jurado AM; Gueglio G
Urol Oncol; 2020 Feb; 38(2):42.e7-42.e12. PubMed ID: 31711833
[TBL] [Abstract][Full Text] [Related]
30. Long-term oncological outcomes after robotic partial nephrectomy for renal cell carcinoma: a prospective multicentre study.
Beauval JB; Peyronnet B; Benoit T; Cabarrou B; Seisen T; Roumiguié M; Pradere B; Khene ZE; Manach Q; Verhoest G; Thoulouzan M; Parra J; Doumerc N; Mathieu R; Vaessen C; Soulié M; Roupret M; Bensalah K
World J Urol; 2018 Jun; 36(6):897-904. PubMed ID: 29427002
[TBL] [Abstract][Full Text] [Related]
31. Low Rate of Cancer Events After Partial Nephrectomy for Renal Cell Carcinoma: Clinicopathologic Analysis of 1994 Cases with Emphasis on Definition of "Recurrence".
Bertolo R; Nicolas M; Garisto J; Magi-Galluzzi C; McKenney JK; Kaouk J
Clin Genitourin Cancer; 2019 Jun; 17(3):209-215.e1. PubMed ID: 31000486
[TBL] [Abstract][Full Text] [Related]
32. [Cryotherapy percutaneous for renal tumors: Our center's beginning experience].
Lalloué F; Ruffion A; Valette PJ; Crouzet S; Martin X; Rouvière O; Paparel P
Prog Urol; 2016 Apr; 26(5):310-8. PubMed ID: 27032313
[TBL] [Abstract][Full Text] [Related]
33. Percutaneous radiofrequency ablation for renal cell carcinoma vs. partial nephrectomy: Comparison of long-term oncologic outcomes in both clear cell and non-clear cell of the most common subtype.
Liu N; Huang D; Cheng X; Chong Y; Wang W; Gan W; Guo H
Urol Oncol; 2017 Aug; 35(8):530.e1-530.e6. PubMed ID: 28408296
[TBL] [Abstract][Full Text] [Related]
34. Transperitoneal Robot-assisted Partial Nephrectomy with Minimum Follow-up of 5 Years: Oncological and Functional Outcomes from a Single Institution.
Bertolo R; Garisto J; Dagenais J; Sagalovich D; Stein R; Fareed K; Gao T; Armanyous S; Fergany A; Lioudis M; Kaouk J
Eur Urol Oncol; 2019 Mar; 2(2):207-213. PubMed ID: 31017098
[TBL] [Abstract][Full Text] [Related]
35. Functional and oncological outcome of percutaneous cryoablation versus laparoscopic partial nephrectomy for clinical T1 renal tumors: A propensity score-matched analysis.
Yanagisawa T; Miki J; Shimizu K; Fukuokaya W; Urabe F; Mori K; Sasaki H; Kimura T; Miki K; Egawa S
Urol Oncol; 2020 Dec; 38(12):938.e1-938.e7. PubMed ID: 33036899
[TBL] [Abstract][Full Text] [Related]
36. Percutaneous Cryoablation of Solitary, Sporadic Renal Cell Carcinoma: Outcome Analysis Based on Clear-Cell versus Papillary Subtypes.
Haddad MM; Schmit GD; Kurup AN; Schmitz JJ; Boorjian SA; Geske J; Thompson RH; Callstrom MR; Atwell TD
J Vasc Interv Radiol; 2018 Aug; 29(8):1122-1126. PubMed ID: 29887184
[TBL] [Abstract][Full Text] [Related]
37. Percutaneous Cryoablation for Stage 1 Renal Cell Carcinoma: Outcomes from a 10-year Prospective Study and Comparison with Matched Cohorts from the National Cancer Database.
Morkos J; Porosnicu Rodriguez KA; Zhou A; Kolarich AR; Frangakis C; Rodriguez R; Georgiades CS
Radiology; 2020 Aug; 296(2):452-459. PubMed ID: 32515677
[TBL] [Abstract][Full Text] [Related]
38. Percutaneous Cryoablation of Clinical T2 (> 7 cm) Renal Masses: Technical Considerations, Complications, and Short-Term Outcomes.
Moynagh MR; Schmit GD; Thompson RH; Boorjian SA; Woodrum DA; Curry TB; Atwell TD
J Vasc Interv Radiol; 2015 Jun; 26(6):800-6. PubMed ID: 25840835
[TBL] [Abstract][Full Text] [Related]
39. Partial nephrectomy versus ablative therapy for the treatment of renal tumors in an imperative setting.
Long JA; Bernhard JC; Bigot P; Lanchon C; Paparel P; Rioux-Leclercq N; Albiges L; Bodin T; Nouhaud FX; Boissier R; Gimel P; Méjean A; Masson-Lecomte A; Grenier N; Cornelis F; Grassano Y; Comat V; Le Clerc QC; Rigaud J; Salomon L; Descotes JL; Sengel C; Roupret M; Verhoest G; Ouzaid I; Arnoux V; Bensalah K;
World J Urol; 2017 Apr; 35(4):649-656. PubMed ID: 27498139
[TBL] [Abstract][Full Text] [Related]
40. Oncologic outcomes of patients with positive surgical margin after partial nephrectomy: a 25-year single institution experience.
Petros FG; Metcalfe MJ; Yu KJ; Keskin SK; Fellman BM; Chang CM; Gu C; Tamboli P; Matin SF; Karam JA; Wood CG
World J Urol; 2018 Jul; 36(7):1093-1101. PubMed ID: 29488096
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
